Increasing malarial drug resistance a growing threat

July 31, 2014
Increasing malarial drug resistance a growing threat
The parasite that causes malaria is growing increasingly resistant to the drugs commonly used to fight it, according to new surveillance reports. But several new drugs are in development, and at least one in early clinical trials may offer new hope.

(HealthDay)—The parasite that causes malaria is growing increasingly resistant to the drugs commonly used to fight it, according to new surveillance reports. But several new drugs are in development, and at least one in early clinical trials may offer new hope.

"Although there has been considerable progress in in the past decade, the battle against malaria is far from won, and there is still much more to do," Brian Greenwood, M.D., professor of at the London School of Hygiene and Tropical Medicine, who wrote a commentary accompanying the new research, told HealthDay. All of the new research, along with Greenwood's editorial, appears in the July 31 issue of the New England Journal of Medicine.

Especially worrisome is the growing power of malaria parasites to survive the drugs that are designed to kill them, Greenwood said. One study reported widespread resistance to the drug artemisinin across mainland Southeast Asia. A second study found resistance to a drug combination—dihydroartemisinin-piperaquine—in Cambodia. Resistance to this drug is particularly concerning because this combination is often used in the most difficult-to-treat malaria infections.

Fortunately, even those who show resistance may get well when given longer courses of medication. "Many of these patients will get better eventually if they are treated for many days or treated with an additional effective drug," Greenwood said, adding that the focus must remain on controlling the spread of , treating those who are sick with existing medications, and developing new drugs to control the disease.

Explore further: Drug-resistant malaria has spread to critical border regions of Southeast Asia

More information: Full Article
Study 1
Study 2
Letter
Editorial

Related Stories

One route to malaria drug resistance found

July 24, 2014

Researchers have uncovered a way the malaria parasite becomes resistant to an investigational drug. The discovery, at Washington University School of Medicine in St. Louis, also is relevant for other infectious diseases including ...

Malaria treatment could improve in children

December 3, 2013

An analysis of patients from across the malaria endemic world suggests that a key antimalarial treatment could be improved by better dosing in young children.

Recommended for you

Kidney stone? Try a roller coaster ride

September 27, 2016

(HealthDay)—Anyone who's suffered a kidney stone just wants the urinary obstruction gone. Now, preliminary research suggests relief might even be fun: a roller coaster ride.

The 'love hormone' may quiet tinnitus

September 23, 2016

(HealthDay)—People suffering from chronic ringing in the ears—called tinnitus—may find some relief by spraying the hormone oxytocin in their nose, a small initial study by Brazilian researchers suggests.

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.